What is a multidisciplinary tumor board and should my Pancreatic Cancer case be presented

Pancreatic CancerJune 4, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Multidisciplinary Tumor Boards for Pancreatic Cancer

What Is a Tumor Board?

A multidisciplinary tumor board is a meeting where a team of cancer experts from different medical specialties comes together to review and discuss an individual patient's case. Think of it as a "consultation meeting" where multiple specialists share their expertise at the same time, rather than you having to see each doctor separately.

According to the NCCN Guidelines for Pancreatic Cancer, this multidisciplinary approach is actually essential for pancreatic cancer care. The guidelines state that "decisions about diagnosis, resectability, and management should involve multidisciplinary consultation at a high-volume center."

Who Sits on a Pancreatic Cancer Tumor Board?

The team typically includes experts such as:

  • Diagnostic radiologists – specialists who read imaging scans
  • Surgical oncologists – surgeons who specialize in cancer
  • Medical oncologists – doctors who prescribe cancer drugs
  • Radiation oncologists – specialists in radiation therapy
  • Pathologists – experts who examine tissue samples
  • Gastroenterologists – specialists in digestive system diseases
  • Interventional radiologists – doctors who perform image-guided procedures
  • Genetic counselors – specialists who explain genetic test results
  • Registered dietitians – nutrition experts
  • Palliative care providers – specialists in symptom management
  • Mental health providers – counselors and social workers

Why Is This Important for Pancreatic Cancer?

Pancreatic cancer is complex, and according to the NCCN Guidelines, the care team should:

✓ Be multidisciplinary – consisting of experts from different medical fields
✓ Work at a high-volume center – a hospital that treats many pancreatic cancer patients and has extensive experience

The NCCN Guidelines emphasize that "because pancreatic cancer is complex, it takes a team of experts to decide the best course to diagnose and treat pancreatic cancer."

Should Your Case Be Presented?

Yes, absolutely. Here's why:

According to the NCCN Guidelines, tumor board review is recommended for:

  • All newly diagnosed pancreatic cancer patients – to determine if surgery is possible and to plan your overall treatment strategy
  • Patients with locally advanced disease – to decide between chemotherapy, radiation, and other options
  • Patients with metastatic disease (cancer that has spread) – to identify the best treatment approach
  • Patients with recurrent cancer – to determine next steps after previous treatment

The guidelines specifically state that multidisciplinary consultation should happen early in your care to help decide critical questions like:

  • Is surgery an option for you?
  • What imaging and testing do you need?
  • What is the best treatment plan?

What Happens at a Tumor Board Review?

When your case is presented, the team will:

  1. **Review your [ID removed] – including your health history and test results
  2. Examine your imaging – CT scans, MRI, and other pictures of your cancer
  3. Discuss your pathology – the details of your tissue biopsy
  4. Consider your molecular profile – special genetic tests of your tumor that may guide treatment
  5. Discuss treatment options – weighing surgery, chemotherapy, radiation, clinical trials, and other approaches
  6. Make recommendations – providing you with expert guidance on the best path forward

Traditional vs. Virtual Tumor Boards

Traditional tumor boards happen at your cancer center, where the team meets in person or by video conference.

Virtual tumor boards are a newer option that brings together experts from multiple institutions across the country. According to resources on pancreatic cancer care, virtual tumor boards can be especially valuable because:

  • About 80% of pancreatic cancer patients are NOT treated at high-volume centers
  • Virtual boards connect you with world-leading experts even if you live far from a major cancer center
  • They provide personalized recommendations you can take back to your local doctor

Organizations like Cancer Commons offer free virtual tumor board consultations specifically for pancreatic cancer patients.

Questions to Ask Your Care Team

To ensure your case gets proper multidisciplinary review:

  1. Will my case be presented to a multidisciplinary tumor board? If not, why not?
  2. Who will be on the tumor board reviewing my case? (Make sure it includes surgeons, medical oncologists, radiologists, and pathologists)
  3. When will the tumor board meet to discuss my case? (This should happen early in your treatment planning)
  4. What are the tumor board's recommendations for my specific situation?
  5. If I'm not at a high-volume pancreatic cancer center, can I get a second opinion from one? Or can my case be reviewed by a virtual tumor board?

Key Takeaway

The NCCN Guidelines strongly recommend that every pancreatic cancer patient have their case reviewed by a multidisciplinary team at a high-volume center. This isn't optional—it's considered standard of care because pancreatic cancer is too complex for any single doctor to manage alone. The combination of expertise leads to better treatment decisions and improved outcomes.

If your current care team hasn't mentioned a tumor board review, it's absolutely appropriate to ask about it.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: